Advertisement

Picture Berlin Partner Hotspot for Startups 650x80px
Document › Details

Gyroscope Therapeutics Ltd.. (3/26/21). "Press Release: Gyroscope Therapeutics Announces Additional Financing Plans". London.

Region Region United States (USA)
Organisations Organisation Gyroscope Therapeutics Ltd.
  Organisation 2 Securities and Exchange Commission (SEC) (US)
  Group United States (govt)
Products Product gene therapy eye disease
  Product 2 investment banking
     


Gyroscope Therapeutics Limited, a clinical-stage gene therapy company focused on treating diseases of the eye, today announced that it expects to consider additional capital raising options this year, which could include an initial public offering in the United States. The timing and the terms of any such additional capital raising have not yet been determined and are subject to market conditions and other factors. There is no assurance that any such additional capital raising will be completed.

This announcement is being made pursuant to and in accordance with Rule 135 under the U.S. Securities Act of 1933, as amended, and does not constitute an offer to sell or the solicitation of an offer to buy securities, and shall not constitute an offer, solicitation or sale in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of that jurisdiction.


Contact:

Charlotte Arnold
VP, Corporate Affairs
Gyroscope Therapeutics
media@gyroscopetx.com

   
Record changed: 2021-04-09

Advertisement

Picture EBD Group Connector Personal Networking in Life Sciences 650x80

More documents for Gyroscope Therapeutics Ltd.


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture [iito] Back into Ad 650x80px




» top